AALL0932- Risk-Adapted Chemotherapy in Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia

Objective

This partially randomized phase III clinical trial is studying different combinations of risk-adapted chemotherapy regimens and their side effects and comparing how well they work in treating younger patients with newly diagnosed standard-risk acute lymphoblastic leukemia.

 http://clinicaltrials.gov/ct2/show/NCT01190930

Location:

Essentia Health Duluth

Disclosures:

None

For more information about a financial conflict of interest (FCOI), review the Essentia Health FCOI policy.

Last Updated: 07/09/2012

Research Study Categories

  • Pediatric Studies

Specialty

  • Cancer
  • Hematology
  • Leukemia
Contact
Cancer Clinical Trials at 218-786-3308